您的当前位置:首页 > 行业数据 > PD-(L)1抑制剂单药或联合化疗方案是无突变基因类型患者的一线标准治疗
图片属性
图片格式:PNG 图片大小:899KB 图片尺寸:2346*1516
同报告图片
 / 4
PD-(L)1抑制剂单药或联合化疗方案是无突变基因类型患者的一线标准治疗_第1页
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
PD-(L)1抑制剂单药或联合化疗方案是无突变基因类型患者的一线标准治疗_第2页
PD-(L)1抑制剂单药或联合化疗方案是无突变基因类型患者的一线标准治疗_第3页
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
PD-(L)1抑制剂单药或联合化疗方案是无突变基因类型患者的一线标准治疗_第4页
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
PD-(L)1抑制剂单药或联合化疗方案是无突变基因类型患者的一线标准治疗_第5页
所属报告: 国产抗体行业(一):从跟随到突破PD~(L)1、VEGF正当时-250715(38页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠